O-GlcNAc modification is an endogenous inhibitor of the proteasome

Cell

Volumn 115, Issue 6, 2003, Pages 715-725

  Zhang, Fengxue ^a   Su, Kaihong ^a   Yang, Xiaoyong ^d   Bowe, Damon B ^b   Paterson, Andrew J ^c   Kudlow, Jeffrey E ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ISOPROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEASOME INHIBITOR; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROL SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROPHOBICITY; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; RAT;

ANIMALIA; MAMMALIA;

EID: 0346965700     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00974-7     Document Type: Article

References (53)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:1997;3797-3804.
2. Adams J., Palombella V.J., Sausville E.A., Johnson J., Destree A., Lazarus D.D., Maas J., Pien C.S., Prakash S., Elliott P.J. Proteasome inhibitors. a novel class of potent and anti-tumor agents Cancer Res. 59:1999;2615-2622.
3. Bajorek M., Finley D., Glickman M.H. Proteasome disassembly and downregulation is correlated with viability during stationary phase. Curr. Biol. 13:2003;1140-1144.
4. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555.
5. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
6. Chen F., Chang D., Goh M., Klibanov S.A., Ljungman M. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ. 11:2000;239-246.
7. Comer F.I., Hart G.W. O-glycosylation of nuclear and cytosolic proteins. dynamic interplay between O-GlcNAc and O-phosphate J. Biol. Chem. 275:2000;29179-29182.
8. DeMartino G.N., Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274:1999;22123-22126.
9. Donath M.Y., Gross D.J., Cerasi E., Kaiser N. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes. 48:1999;738-744.
10. Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins. cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain J. Biol. Chem. 276:2001;9838-9845.
11. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway. destruction for the sake of construction Physio. Rev. 82:2002;373-482.
12. Goldberg A.L., Rock K. Not just research tools - proteasome inhibitors offer therapeutic promise. Nat. Med. 8:2002;338-340.
13. Haltiwanger R.S., Blomberg M.A.A., Hart G.W. Glycosylation of nuclear and cytoplasmic proteins. purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyl transferase J. Biol. Chem. 267:1992;9005-9013.
14. Han I., Kudlow J.E. Reduced O-glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17:1997;2550-2558.
15. Han I., Oh E.S., Kudlow J.E. Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem. J. 350:2000;109-114.
16. Hanover J.A. Glycan-dependent signaling. O-linked N-acetylglucosamine FASEB J. 15:2001;1865-1876.
17. Hanover J.A., Lai Z., Lee G., Lubas W.A., Sato S.M. Elevated O-linked N-acetylglucosamine metabolism in pancreatic β-cells. Arch. Biochem. Biophys. 362:1999;38-45.
18. Hattendorf D.A., Lindquist S.L. Cooperative kinetics of both Hsp104 ATPase domains and interdomain communication revealed by AAA sensor-1 mutants. EMBO J. 21:2002;12-21.
19. Hideshima T., Richardson P., Chauhan D., Palombella V.J., Elliott P.J., Adams J., Anderson K.C. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myoloma cells. Cancer Res. 61:2001;3071-3076.
20. Hoffman L., Rechsteiner M. Nucleotidase activities of the 26S proteasome and its regulatory complex. J. Biol. Chem. 271:1996;32538-32545.
21. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
22. Jackson S.P., Tjian R. O-glycosylation of eukaryotic transcription factors. implications for mechanisms of transcriptional regulation Cell. 55:1988;125-133.
23. Jagoe R.T., Lecker S.H., Gomes M., Goldberg A.L. Patterns of gene expression in atrophying skeletal muscles. response to food deprivation FASEB J. 16:2002;1697-1712.
24. Kisselev A.F., Goldberg A.L. Proteasome inhibitors. from research tool to drug candidates Chem. Biol. 8:2001;739-758.
25. Köhler A., Cascio P., Leggett D.S., Woo K.M., Goldberg A.L., Finley D. The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol. Cell. 7:2001;1143-1152.
26. Krepple L.K., Blomberg M.A., Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats J. Biol. Chem. 272:1997;9308-9315.
27. Lecker S.H., Goldberg A.L. Slowing muscle atrophy. putting the brakes on protein breakdown J. Physiol. 545:2002;819-828.
28. Lee D.H., Goldberg A.L. Proteasome inhibitors. valuable new tools for cell biology Trends Cell Biol. 8:1998;397-403.
29. Li B., Dou Q.P. Bax degradation by the ubiquitin/proteasome dependent pathway. involvement in tumor survival and progression Proc. Natl. Acad. Sci. USA. 97:2000;3850-3855.
30. Liu K., Paterson A.J., Chin E., Kudlow J.E. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells. linkage of O-linked GlcNAc to β cell death Proc. Natl. Acad. Sci. USA. 97:2000;2820-2825.
31. Lopes U.G., Erhardt P., Yao R., Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272:1997;12893-12896.
32. Lubas W.A., Frank D.W., Krause M., Hanover J.A. O-linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272:1997;9316-9324.
33. Matschinsky F.M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 45:1996;223-241.
34. Mitch W.E., Goldberg A.L. Mechanisms of muscle wasting. the role of the ubiquitin-proteasome pathway N. Engl. J. Med. 335:1996;1897-1905.
35. Moss B. Vaccinia virus. a tool for research and vaccine development Science. 252:1991;1662-1667.
36. Navon A., Goldberg A.L. Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome. Mol. Cell. 8:2001;1339-1349.
37. Pasquini L.A., Moreno M.B., Adamo A.M., Pasquini J.M., Soto E.F. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59:2000;601-611.
38. Price S.R., Bailey J.L., Wang X., Jurkovitz C., England B.K., Ding X., Philips L.S., Mitch W.E. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. 98:1996;1703-1708.
39. Qiu J.H., Asai A., Chi S., Saito N., Hamada H., Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured corticle neurons. J. Neurosci. 20:2000;259-265.
40. Roos M.D., Su K., Baker J., Kudlow J.E. O-glycosylation of a Sp1-derived peptide blocks known Sp1 protein interaction. Mol. Cell. Biol. 17:1997;6472-6480.
41. Roos M.D., Xie W., Su K., Clark J.A., Yang X., Chin E., Paterson A.J., Kudlow J.E. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc. Assoc. Am. Physicians. 110:1998;422-432.
42. Rubin D.M., Glickman M.H., Larsen C.N., Dhruvakumar S., Finley D. Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome. EMBO J. 17:1998;4909-4919.
43. Russell S.J., Gonzalez F., Joshua-Tor L., Johnston S.A. Selective chemical inactivation of AAA proteins reveals distinct functions of proteasomal ATPases. Chem. Biol. 8:2001;941-950.
44. Sayeski P.P., Kudlow J.E. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J. Biol. Chem. 271:1996;15237-15243.
45. Sweet R.M., Eisenberg D. Correlation of sequence hydrophobicities measures similarity in three-dimensional protein structure. J. Mol. Biol. 171:1983;479-488.
46. Su K., Roos M.D., Yang X., Han I., Paterson A.J., Kudlow J.E. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J. Biol. Chem. 274:1999;15194-15202.
47. Su K., Yang X., Roos M.D., Paterson A.J., Kudlow J.E. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem. J. 348:2000;281-289.
48. Voges D., Zwickl P., Baumeister W. The 26S proteasome. a molecular machine designed for controlled proteolysis Annu. Rev. Biochem. 68:1999;1015-1068.
49. Wells L., Vosseller K., Hart G.W. Glycosylation of nucleocytoplasmic proteins. Signal transduction and O-GlcNAc Science. 291:2001;2376-2378.
50. Wells L., Whalen S.A., Hart G.W. O-GlcNAc. a regulatory post-translational modification Biochem. Biophys. Res. Commun. 302:2003;435-441.
51. Wing S.S., Goldberg A.L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264:1993;E668-E676.
52. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA. 98:2001;6611-6616.
53. Yang X., Zhang F., Kudlow J.E. Recruitment of O-GlcNAc transferase to promoters by corepresser mSin3A. coupling protein O-GlcNAcylation to transcription regulation Cell. 110:2002;69-80.